Combination of Tryptase and IL-33 in Bronchoalveolar Lavage Fluid May Predict the Types of Eosinophilic Pneumonia and Disease Recurrence

Combination of Tryptase and IL-33 in Bronchoalveolar Lavage Fluid May Predict the Types of Eosinophilic Pneumonia and Disease Recurrence - Tryptase and IL-33 in BALF of EP patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000044077

Enrollment

Registered

2021-04-29

Start date

2006-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients diagnosed with eosinophilic pneumonia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who was diagnosed with eosinophilic pneumonia

Exclusion criteria

Exclusion criteria: history of malignancy, idiopathic eosinophilia

Design outcomes

Primary

Measure	Time frame
tryptase and IL-33 in BALF	—

Countries

Japan

Contacts

Public ContactTomohiro Akaba

Tokyo Women's Medical University Department of respiratory medicine

akaba.tomohiro@twmu.ac.jp81-3-3353-8111

Outcome results